Press release
Leukocyte Adhesion Deficiency Management Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends
Leukocyte Adhesion Deficiency Management Market
The escalating occurrence of primary immunodeficiency is predicted to spur the expansion of the leukocyte adhesion deficiency management market in the future. Primary immunodeficiency (PID) involves a cluster of inherited ailments that undermine the immune system, rendering individuals more prone to infections and diseases due to flaws in their immune reactions. Handling leukocyte adhesion deficiencies contributes to primary immunodeficiency by enhancing the comprehension of immune system maladies and possibly paving the way for better diagnostic equipment and treatments for both conditions. For example, as reported by Peace Hospital, an India-based multi-specialty healthcare center, statistics collected during the World Primary Immunodeficiency (WPI) Awareness Week 2023 reveal that primary immunodeficiency (PI) impacts an estimated 60 lakh individuals worldwide, with between 70% to 90% of people remaining undiagnosed for primary immunodeficiency. Hence, the rising occurrence of primary immunodeficiency will boost the leukocyte adhesion deficiency management market's expansion. The leukocyte adhesion deficiency management market is projected to be driven by the growing prevalence of spinal cord injuries. A spinal cord injury results from harm done to any segment of the spinal cord or the nerves at the spinal canal's termination (cauda equina). This injury can lead to autonomic malfunction, including hyperhidrosis, connected to overactive sympathetic response by the spinal cord's cephalad part below the injury zone. For instance, data from the National Spinal Cord Injury Statistical Center (NSCISC), a US-based division that oversees the gathering, handling, and evaluation of spinal cord injury research databases, in March 2022 reflects that the yearly rate of traumatic spinal cord injury (SCI) is about 54 incidents per million individuals in the US, equivalent to about 18,000 fresh SCI cases annually. The estimated population of people in the US with SCI falls between 253,000 and 378,000, with an approximate figure of 299,000. Consequently, the growing occurrence of spinal cord injuries prompts the leukocyte adhesion deficiency management market's growth.
Get Your Leukocyte Adhesion Deficiency Management Market Report Here:
https://www.thebusinessresearchcompany.com/report/leukocyte-adhesion-deficiency-management-global-market-report
How will the growth rate of the leukocyte adhesion deficiency management market shape industry trends by 2034?
The market for managing leukocyte adhesion deficiency has experienced robust expansion in recent years. The market that stood at $8.07 billion in 2024 will increase to $8.61 billion in 2025, translating to a compound annual growth rate (CAGR) of 6.7%. Factors such as heightened awareness and education, progress in genetic testing, the introduction of orphan drugs, worldwide health policies, advocacy groups for patients, and improvements in pediatric healthcare have contributed to growth during the historical time-frame.
Expectations are high for substantial growth in the leukocyte adhesion deficiency management market in the upcoming years. The market is anticipated to expand to $11.25 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. This projected growth for the forecast period could be due to the rise of precision medicine strategies, emergence of advanced therapeutics, increased accessibility to genetic testing, a focus on patient-oriented drug development, and progress in immunomodulatory treatments. Emerging trends during the forecast period comprise innovations in stem cell transplantation, incorporation of supportive therapies, use of telemedicine for remote consultations, collaboration, and research networks, and the inclusion of biomarker technologies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13172&type=smp
What trends are poised to drive the future success of the leukocyte adhesion deficiency management market?
Leading firms involved in the leukocyte adhesion deficiency management market are optimizing lentiviral vector-based gene therapy technology to elevate targeted interventions and augment patient results. This gene therapy, based on lentiviral vectors, provides a specific strategy in managing leukocyte adhesion deficiency, by transporting corrective genes straight into cells, with the potential to reinstate immune function. For example, in February 2024, Rocket Pharmaceuticals, an American biotechnology company, introduced kresladi (marnetegragene autotemcel) to treat severe leukocyte adhesion deficiency-I (LAD-I). It accomplished 100% survival rates at 12 months in a Phase 1/2 trial, notably reducing infections and ameliorating symptoms. Kresladi brings a revolutionary alternative to the LAD management market, fulfilling essential unmet needs.
Which primary segments of the leukocyte adhesion deficiency management market are driving growth and industry transformations?
The leukocyte adhesion deficiency management market covered in this report is segmented -
1) By Treatment: Hematopoietic Stem Cell Transplantation, Recombinant Human Interferon-Gamma Treatment, Prophylactic Immunoglobulin Therapy, Antimicrobial Therapy, Prophylactic Therapy, Fucose Supplementation, Monoclonal Antibodies, Coagulation Factors
2) By Diagnosis: Blood Test, Genetic Testing, Biopsy, Other Types
3) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Hematopoietic Stem Cell Transplantation: Related Donor Transplant, Unrelated Donor Transplant
2) By Recombinant Human Interferon-Gamma Treatment: Standard Dosing, Customized Dosing
3) By Prophylactic Immunoglobulin Therapy: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
4) By Antimicrobial Therapy: Antibiotics, Antifungal Treatments
5) By Prophylactic Therapy: Vaccination Strategies, Infection Prevention Protocols
6) By Fucose Supplementation: Oral Supplements, Intravenous Supplements
7) By Monoclonal Antibodies: Specific Target Monoclonal Antibodies, Combination Therapy Monoclonal Antibodies
8) By Coagulation Factors: Factor Replacement Therapies, Novel Coagulation Agents
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13172
Which geographical regions are pioneering growth in the leukocyte adhesion deficiency management market?
North America was the largest region in the leukocyte adhesion deficiency management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukocyte adhesion deficiency management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the influential players reshaping the leukocyte adhesion deficiency management market landscape?
Major companies operating in the leukocyte adhesion deficiency management market report are F. Hoffmann-La Roche Ltd., Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Teva Pharmaceuticals Industries Limited, CSL Behring LLC, Vertex Pharmaceuticals Inc., Grifols International S.A., Aurobindo Pharma Ltd., BioMarin Pharmaceutical Inc., Cadila Healthcare Ltd., Ipca Laboratories Ltd., Sana Biotechnology Inc., Rocket Pharmaceuticals Inc., PT Sanbe Farma, Magenta Therapeutics Inc., Avalo Therapeutics Inc., Aspen Neuroscience Inc., Sandoz International GmbH, Orpha Labs Inc., Swiss Pharm Holding AG, Rubius Therapeutics Inc., Enochian Biosciences Inc., Sigma-Aldrich LLC, Bluebird Bio Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13172&type=smp
What Is Covered In The Leukocyte Adhesion Deficiency Management Global Market Report?
•Market Size Forecast: Examine the leukocyte adhesion deficiency management market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the leukocyte adhesion deficiency management market for a structured understanding.
•Key Players Overview: Analyze major players in the leukocyte adhesion deficiency management market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the leukocyte adhesion deficiency management market.
•Segment Contributions: Evaluate how different segments drive overall growth in the leukocyte adhesion deficiency management market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the leukocyte adhesion deficiency management market.
•Industry Challenges: Identify potential risks and obstacles affecting the leukocyte adhesion deficiency management market.
•Competitive Landscape: Review strategic developments in the leukocyte adhesion deficiency management market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leukocyte Adhesion Deficiency Management Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends here
News-ID: 3913981 • Views: …
More Releases from The Business Research Company
Rising Global Incidence Of Chronic Diseases Fueling The Diagnostic Imaging Equip …
"What Are the Projected Growth and Market Size Trends for the Diagnostic Imaging Equipment Market?
In recent years, the diagnostic imaging equipment market has seen robust growth. With a compound annual growth rate (CAGR) of 6.9%, it is projected to increase from $56.96 billion in 2024 to $60.86 billion in 2025. This growth during the historic period is due to factors such as an aging population, an increase in disease burden,…
Deep Sea, Coastal, And Great Lakes Market Forecast 2025-2034: Evaluating Growth …
"What Is the Forecasted Market Size and Growth Rate for the Deep Sea, Coastal, And Great Lakes Market?
The market size for the deep sea, coastal, and great lakes has exhibited robust growth in recent years. The market value is projected to escalate from $594.12 billion in 2024 to $630.33 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. This growth throughout the historical phase can be credited…
Shaping the Consumer Drones Market in 2025: Innovative Dji Mini 4 Pro Sets New S …
"How Big Is the Consumer Drones Market Expected to Be, and What Will Its Growth Rate Be?
Recent years have seen a swift expansion in the size of the consumer drones market. The market value, which stands at $6.64 billion in 2024, is predicted to rise to $7.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 18.1%. Factors contributing to the growth during the historic period include a…
Leading Growth Driver in the Collaboration Software Market in 2025: Remote Work' …
"What Are the Market Size and Growth Forecast for the Collaboration Software Market?
The market size for collaboration software has seen consistent growth over the past few years. The market value is expected to increase from $13.83 billion in 2024 to $14.26 billion in 2025, with a compound annual growth rate (CAGR) of 3.1%. Factors such as globalization and the rise of remote work, greater adoption of cloud computing, increased mobility…
More Releases for Therapy
Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023.
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand…
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market.
Factors that are likely to hamper the growth of the market…
